Cart
sales@molnova.com
JNJ-38893777 sulfate
CAS No. 951135-07-2
JNJ-38893777 sulfate( JNJ38893777 )
Catalog No. M16803 CAS No. 951135-07-2
JNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJNJ-38893777 sulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.
-
DescriptionJNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.Pain Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsJNJ38893777
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRP/TRPV Channel
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number951135-07-2
-
Formula Weight634.598
-
Molecular FormulaC26H28F6N6O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name2-(1-piperidinyl)-N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)-2-pyridinyl]-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepin-4-amine sulfate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Manitpisitkul P, et al. Clin Drug Investig. 2015 Jun;35(6):353-63.
2. Meents JE, et al. J Headache Pain. 2015;16:57.
molnova catalog
related products
-
AMG2850
AMG2850 is a potent, orally bioavailable, and selective antagonist of transient receptor potential melastatin 8 (TRPM8).
-
Pyr6
Pyr6 is a selective TRPC3 inhibitor with IC50 of 0.49 uM(Ca2+ influx inhibition in thapsigargin depleted native RBL-2H3 cells).Pyr6 is an inhibitor of Ca2+ entry, which displays higher potency to inhibit Ca2+ entry mediated by CRAC channel than by TRPC3.Pyr3 is selective inhibitor of TRPC3, inhibited Orai1- and TRPC3-mediated Ca(2+) entry and currents as well as mast cell activation with similar potency.?
-
JT010
JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).
